Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT06052150 · ClinicalTrials.gov registry record
Oral Health In Cirrhosis of the Liver (ORACLE)
A clinical trial of Cirrhosis and Periodontal Diseases, sponsored by Hunter Holmes Mcguire Veteran Affairs Medical Center.
- Recruiting
- Registry status
- 100
- Enrollment target
- 2
- Study locations
NCT06052150: Recruiting study of Cirrhosis and Periodontal Diseases, sponsored by Hunter Holmes Mcguire Veteran Affairs Medical Center.
NCT06052150 is a study of Cirrhosis and Periodontal Diseases that is actively recruiting participants, run by Hunter Holmes Mcguire Veteran Affairs Medical Center. The registered enrollment target is 100 participants, below the 90,407-participant average among 53 other Cirrhosis trials with a reported enrollment target (100% lower). The trial reports 2 study locations across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT06052150, a study of Cirrhosis and Periodontal Diseases, is actively recruiting participants, sponsored by Hunter Holmes Mcguire Veteran Affairs Medical Center.
- RECRUITING
- Registry status
- 100 participants
- Enrollment target
- 2
- Study locations
Study Summary
The goal of this observational study is to learn about dental evaluation and periodontal cleaning along with scheduled follow -up on the dental health and overall health of patients with cirrhosis and also to determine what barrier(s) if any exist to improve oral health in this population.
Primary Outcome
Barriers towards dental care will be inquired using a semi-quantitative questionnaire Will be a yes or no answer
Conditions Studied
Interventions
- PROCEDURE Dental exam and periodontal cleaning if needed
Study Locations (2)
Virginia
- Hunter Holmes McGuire VA Medical Center - Richmond
- Virginia Commonwealth University - Richmond
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 100 participants |
| Start Date | 2023-09-18 |
| Est. Completion | 2025-12-31 |
What NCT06052150 shows while recruiting
NCT06052150 is an observational study that tracks outcomes without assigning an intervention. The registered 100 participants enrollment target is mid-sized for trials with a published cap, below the 90,407-participant average among 53 other Cirrhosis trials with a reported enrollment target (100% lower).
The record links to 2 conditions, with Cirrhosis appearing as the primary indexed condition, and to 1 intervention - of which Dental exam and periodontal cleaning if needed is the first listed.
NCT06052150 reports a single indexed study location in Virginia.
Frequently Asked Questions
What is clinical trial NCT06052150 about?
NCT06052150 is a clinical study titled "Oral Health In Cirrhosis of the Liver (ORACLE)". The goal of this observational study is to learn about dental evaluation and periodontal cleaning along with scheduled follow -up on the dental health and overall health of patients with cirrhosis and also to determine what barrier(s) if any exist to improve oral health in this population.
What is the current status of trial NCT06052150?
This trial is currently recruiting. The enrollment target is 100 participants. The study started on 2023-09-18. Estimated completion is 2025-12-31.
What conditions does trial NCT06052150 study?
This clinical trial studies the following conditions: Cirrhosis, Periodontal Diseases.
What interventions are being tested in trial NCT06052150?
The interventions under investigation include: Dental exam and periodontal cleaning if needed (PROCEDURE).
Who is sponsoring clinical trial NCT06052150?
This trial is sponsored by Hunter Holmes Mcguire Veteran Affairs Medical Center, which has 27 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT06052150 being conducted?
This trial has 2 study locations across Virginia. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Cirrhosis
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT06052150's enrollment target sits among peer trials
100 18th of 53 higher than 35 of 53 other Cirrhosis trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Cirrhosis trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Mechanisms of Malnutrition in Cirrhosis With Portosystemic Shunting
RECRUITING
-
LiverSleep: A Behavioral Sleep Intervention for Patients With Cirrhosis and Insomnia
RECRUITING · NA
-
Droxidopa to Increase Mean Arterial Pressure in Decompensated Cirrhosis Patients With Acute Kidney Injury
RECRUITING · Phase 2
-
A Prospective Study of Memantine in Patients With Cirrhosis and Liver Cancer
RECRUITING · Phase 2
-
Namodenoson in the Treatment of Advanced Hepatocellular Carcinoma in Patients With Child-Pugh Class B7 Cirrhosis
RECRUITING · Phase 3
-
Hepatic Impairment With Cirrhosis Due to Cholestatic Liver Disease
RECRUITING · Phase 1
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT01048281 · 100 participants
Clinical & Pathological Studies of Upper Gastrointestinal Carcinoma
- NCT01161199 · 100 participants
The Use of Leukapheresis to Support HIV Pathogenesis Studies
- NCT01327690 · 100 participants · Early Phase 1
Mental Health in Veterans and Families After Group Therapies
- NCT01730781 · 100 participants
Imaging Cannabinoid Receptors Using Positron Emission Tomography (PET) Scanning
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI